<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="45260">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01952626</url>
  </required_header>
  <id_info>
    <org_study_id>KNUH 2013-03-032-001</org_study_id>
    <nct_id>NCT01952626</nct_id>
  </id_info>
  <brief_title>Prevention of Intrathecal Morphine Induced Pruritus: Comparison of Ondansetron and Palonosetron</brief_title>
  <official_title>Prevention of Intrathecal Morphine Induced Pruritus: Comparison of Ondansetron and Palonosetron</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kyungpook National University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kyungpook National University</source>
  <oversight_info>
    <authority>Korea: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intrathecal administration of morphine is often used for control of postoperative pain.
      However, pruritus is one of the most common side effects of intrathecal morphine . Specific
      serotonin receptor antagonists could be an effective prophylactic treatment of neuraxial
      opioid-induced pruritus. It was reported that palonosetron is more effective than
      ondansetron for prevention of postoperative nausea and vomiting. Therefore, the
      investigators evaluated the efficacy of prophylactic administration of ondansetron and
      palonosetron for the prevention of intrathecal morphine-induced pruritus.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Intrathecal administration of morphine is often used for relief of postoperative pain.
      However, pruritus is one of the most common side effects associated with intrathecal
      morphine. Specific serotonin receptor antagonists such as ondansetron could be an effective
      prophylactic treatment of neuraxial opioid-induced pruritus. It was reported that
      palonosetron is more effective than ondansetron for prevention of postoperative nausea and
      vomiting. Therefore, the investigators evaluated the efficacy of prophylactic administration
      of ondansetron and palonosetron for the prevention of intrathecal morphine-induced pruritus.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">June 2014</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Incidence of pruritus</measure>
    <time_frame>24 hours after spinal anesthesia</time_frame>
    <safety_issue>No</safety_issue>
    <description>record of the incidence of pruritus after spinal anesthsia</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Morphine Adverse Reaction</condition>
  <arm_group>
    <arm_group_label>ondansetron</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intravenous administration of ondansetron 4mg 15 minutes before spinal anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>palonosetron</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intravenous administration of palonosetron 0.075mg 15 minutes before spinal anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ondansetron</intervention_name>
    <description>intravenous injection</description>
    <arm_group_label>ondansetron</arm_group_label>
    <other_name>zofran</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Palonosetron</intervention_name>
    <description>intravenous injection</description>
    <arm_group_label>palonosetron</arm_group_label>
    <other_name>aloxi</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  19-70 years,

          -  American Society of Anesthesiology physical status 1 and 2

          -  Scheduled for elective urologic surgery under spinal anesthesia.

        Exclusion Criteria:

          -  Patients with cardiac and psychological problems.

          -  Patients who take sedatives or narcotics.

          -  Patient who have allergy to study drugs.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Younghoon Jeon, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kyungpook  National University Hopsital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kyungpook National Hospital</name>
      <address>
        <city>Daegu</city>
        <zip>700-721</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kibum Park, Dr</last_name>
      <phone>82534205877</phone>
      <email>pakkibum@naver.com</email>
    </contact>
    <investigator>
      <last_name>Yougnhoon Jeon, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 25, 2013</lastchanged_date>
  <firstreceived_date>June 11, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kyungpook National University</investigator_affiliation>
    <investigator_full_name>Younghoon Jeon</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>intrathecal</keyword>
  <keyword>morphine</keyword>
  <keyword>ondansetron</keyword>
  <keyword>palonosetron</keyword>
  <keyword>pruritus</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pruritus</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Ondansetron</mesh_term>
    <mesh_term>Palonosetron</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
